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Abstract
Intestinal epithelial cell damage is frequently seen in the mucosal lesions of inflammatory bowel diseases such as ulcerative
colitis or Crohn’s disease. Complete remission of these diseases requires both the cessation of inflammation and the
migration of enterocytes to repair the damaged epithelium. Lyophilized Saccharomyces boulardii (Sb, Biocodex) is a
nonpathogenic yeast widely used as a therapeutic agent for the treatment and prevention of diarrhea and other
gastrointestinal disorders. In this study, we determined whether Sb could accelerate enterocyte migration. Cell migration
was determined in Sb force-fed C57BL6J mice and in an in vitro wound model. The impact on a2b1 integrin activity was
assessed using adhesion assays and the analysis of a2b1 mediated signaling pathways both in vitro and in vivo.W e
demonstrated that Sb secretes compounds that enhance the migration of enterocytes independently of cell proliferation.
This enhanced migration was associated with the ability of Sb to favor cell-extracellular matrix interaction. Indeed, the yeast
activates a2b1 integrin collagen receptors. This leads to an increase in tyrosine phosphorylation of cytoplasmic molecules,
including focal adhesion kinase and paxillin, involved in the integrin signaling pathway. These changes are associated with
the reorganization of focal adhesion structures. In conclusion Sb secretes motogenic factors that enhance cell restitution
through the dynamic regulation of a2b1 integrin activity. This could be of major importance in the development of novel
therapies targeting diseases characterized by severe mucosal injury, such as inflammatory and infectious bowel diseases.
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Introduction
The colonic epithelium forms a continuous physical and
functional barrier that protects the internal environment of the
body from the fluctuating external milieu. Various substances
including dietary elements, gastrointestinal secretory products and
drugs are known to disrupt this epithelial barrier, leading to the
shedding of epithelial cells and the development of wounds [1]. In
addition inflammatory bowel diseases (IBD), including ulcerative
colitis and Crohn’s disease, are characterized by varying degrees of
mucosal surface damage, chronic inflammation and mucosal
ulceration, resulting in the subsequent impairment of the barrier
function [2]. Moreover, infection of the colonic mucosa by
bacterial pathogens including Shigella, Salmonella or Clostridium
difficile results in the development of acute intestinal inflammatory
diseases and destruction of the intestinal epithelium [3,4]. The
colonic barrier has a striking ability to rapidly reseal superficial
wounds, which is critical for the maintenance of barrier function
and homeostasis. As with other epithelia of the gastrointestinal
tract, the repair of damaged colonic mucosa initially requires cell
migration to restore epithelial continuity [1]. This process, termed
restitution, is followed by the proliferation and subsequent
maturation and differentiation of the cells, allowing the restoration
of normal architecture and absorptive/secretory function.
Intestinal restitution has been found to be influenced by a broad
spectrum of factors derived from the gastrointestinal environment,
including host epithelial and lamina propria cells, resident
microbiota, and the dietary and non-dietary components present
in the gastrointestinal lumen [2]. Moreover, dynamic and
reciprocal crosstalk between receptors for soluble factors and
those for the extracellular matrix (ECM) play a crucial role in the
regulation of this process [5,6,7].
Integrins constitute the main cell surface adhesion receptors
mediating cell-ECM adhesion. These transmembrane heterodi-
meric molecules are made up of non-covalently bound a and b
subunits. In mammals, 18 a and 8 b subunits combine to form 24
distinct integrin receptors that bind various ECM ligands with
different affinities [8]. Integrins allow a bi-directional flow of
mechanochemical information across the plasma membrane and
facilitate interactions between the ECM and the actin cytoskeleton.
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membrane, are dynamically linked. The cytoskeleton controls the
functional state of the integrins thus modulating their interaction
with the ECM. Meanwhile integrin binding to the ECM changes
the cell shape and the composition of the cytoskeleton beneath [8].
The nonpathogenic yeast Saccharomyces boulardii (Sb) is widely
used in a lyophilized form to treat and prevent antibiotic-
associated and infectious diarrhea [9]. Recent in vitro and in vivo
studies indicate that Sb interacts not only with pathogenic micro-
organisms and resident microflora, but also with intestinal mucosa
[10,11]. In addition Sb has been shown to exert a trophic effect
that restores intestinal homeostasis [11]. Furthermore, clinical
trials have suggested that Sb can be effective in the treatment of
IBD [12,13] through the modulation of host cell signaling
pathways implicated in the proinflammatory response [14,15,
16]. However, no information is currently available on the possible
effects of Sb upon colonic epithelial cell restitution.
In the present study, we show that Sb secretes factors that
modulate intestinal epithelial cell restitution both in vitro and in vivo.
Our findings suggest that Sb increases intestinal epithelial cell
migration without affecting cell proliferation. Sb exerts at least
some of its motogenic effects through the activation of the a2b1
integrin collagen receptor signaling pathway, which is associated
with the reorganization of focal adhesions.
Methods
Cell culture
The human colonic adenocarcinoma cell lines HCT-8/E11,
CaCo2/TC7, HT29-D4 and T84, were routinely cultured as
previously described [17,18,19,20]. Cells were cultured on plastic
dishes until they reached confluency. These cellular monolayers
consist of polarized cells joined by tight junctions, exhibiting well
developed apical microvilli, which allow the study of the processes
involved in intestinal epithelial cell physiology.
Yeast culture supernatants
The supernatants of Sb (Biocodex laboratories; Gentilly, France)
and Saccharomyces cerevisiae (Sc, strain BY4742, a gift from C. De La
Roche Saint-Andre ´; CNRS, Marseille, France) were prepared as
previously described [21]. Briefly, yeast strains (100 mg/ml) were
cultured overnight at 37uC in epithelial cell culture media.
Conditioned media were centrifuged at 20,0006g for 15 minutes
and the supernatants collected. The supernatants were passed
through 0.22 mm filters (Fisher Scientific) to remove yeast cells.
Serial dilutions ranging from 1/8 to 1/128 were performed in
epithelial cell culture media. None of the diluted supernatants
affected cell viability, as verified by the trypan blue exclusion test.
Wound healing model
Monolayers of differentiated cells were wounded using a sterile
tooth-pick and incubated with or without various dilutions of Sb
supernatant. Plates were placed in a temperature and CO2-
controlled chamber mounted on a Nikon TE2000 inverted
microscope. Images were captured every 5 minutes for a total
observation period of 5 hours using a Cool SnapHQ camera
(Princeton Instruments) through a 106 objective lens. For each
wound, 10 measurements of wound width were recorded. To assess
the role of the integrins in Sb enhanced enterocyte migration,
10 mg/ml function-blocking anti-integrin monoclonal antibodies
(mAbs) (GoH3 (anti-a6), 69.6.5 (anti-av), Lia1/2 (anti-b1), Gi9
(anti-a2), and SAM-1 (anti-a5); Beckman Coulter, Marseille,
France), b1-activating mAb (TS2/16; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) or anti DPP IV mAb (S. Maroux, CNRS,
Marseille) were added 1 hour before wounding and again during
the period of cell migration. In some experiments, MAPK inhibitor
(10 mM PD 98059; Tocris Bioscience, Bristol, UK ) or 10 nM FAK
inhibitor (PF 573228; Tocris Bioscience) were added 1 hour before
wounding and again during the period of cell migration. When
required, cells were treated with 2.5 mg/mL mitomycin C (Sigma)
prior and during cell migration in order to block cell proliferation.
In order to track the rate of cell proliferation, 10 mmol/L 5-bromo-
29-deoxyuridine (BrdU) was added 4 hours after the wound and
incubationcontinuedforanadditional1 hourperiod.Cellsthathad
incorporated BrdU into their DNA were detected using the BrdU
labeling and detection kit according to the manufacturer’s
instructions (Roche, Mannheim, Germany). Cell proliferation in
wounded monolayers was visualized by light microscopy using an
inverted Olympus CKX41 microscope.
Measurement of enterocyte crypt-villus migration
Groups of 6-week old C57BL6J female mice (n=5) were force-fed
daily with 200 mL PBS solution with or without 1 mg/ml lyophilized
Sb for 1 week. When required, mice were force-fed daily for one week
with 200 mL Sb supernatant or Sc supernatant. Animals were injected
with BrdU (50 mg/kg, BrdU; Sigma) intraperitoneally and then
sacrificed 24 hours later. Segments of intestine were frozen in liquid
nitrogen and cryosectioning (section thickness: 8 mm) was performed.
Samples were immunostained with a rat anti-BrdU antibody mAb
(Abcam) overnight at 4uC. After washing, sections were incubated
with AlexaFluor 488-conjugated goat anti-rat IgG (Invitrogen) for
1 hour, and then mounted in ProLong Gold medium containing
DAPI (Invitrogen) in order to couterstain nuclei. Images were
captured and analyzed using a Leica DM IRBE microscope.
Enterocyte migration was determined by measuring the distance
from the bottom of the crypt to the foremost labeled enterocyte and
expressing the distance as a percentage of the total villus height. All
animal experiments were performed in accordance with the
regulations of our institution’s ethics commission. They were
conducted following the APS Guiding Principles in the Care and Use of
Animals. The study was approved by the Ethics Committee in Animal
Experimentation of Centre Me ´diterrane ´en de Me ´decine Mole ´culaire
(C3M), Nice, France (protocol 3/2010).
Cell adhesion assay
Cell adhesion assays on Laminin-111 (Sigma, Saint Quentin
Fallavier, France) and type I collagen (BD-Bioscience, Belford,
MA, USA) were performed using cells incubated with or without
Sb supernatant, as previously published [22]. Function blocking
anti-integrin mAbs (10 mg/mL) were added to a subset of samples,
to identify the receptor types involved in Sb enhanced adhesion.
Immunocytochemistry and Immunohistochemistry
Cells, incubated with or without Sb supernatant, were fixed and
permeabilized as previously described [23]. Paxillin was immuno-
stained with a mouse anti-paxillin mAb (Millipore). Tissues were
fixed in acetone for 10 minutes at -20uC, and stained with rat anti-
ki-67 (Abcam), rat anti-a6 integrin (Beckman coulter), rabbit anti-
a2 integrin (Millipore) or rabbit anti-Y118 Paxillin (Millipore) Abs.
After washing, samples were incubated with the appropriate Alexa
488- or Alexa 546-conjugated secondary Abs (Invitrogen), and
then mounted in ProLong Gold medium. Images were captured
and analyzed using a Leica DM IRBE microscope.
Detection of tyrosine-phosphorylated proteins
Single-cell suspensions (25 000 cells/0.1 mL), prepared in
DMEM containing 0.2% BSA (adhesion buffer), were seeded onto
S. boulardii Enhances Cell Restitution
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e18427type I collagen-coated wells and allowed to adhere for periods
ranging from 0 to 30 minutes. Adherent cells were lyzed as
previouslypublished [24].Equalamounts ofcell lysates(50 mg)were
resolved by SDS-PAGE and blotted onto a nitrocellulose sheet.
Membranes were blocked with PBS containing 5% non-fat dry milk
and probed overnight at 4uC with Abs directed against rabbit
phospho ERK1/2 (Ozyme, St. Quentin en Yvelines, France),
mouse anti-Y397-FAK (Invitrogen) or rabbit anti-Y118-paxillin
(Millipore). Blots were then revealed by chemiluminescence after
incubation with the appropriate horseradish peroxidase-conjugated
secondary Ab (Amersham). Loading amounts were verified by
probing the blot with rabbit-anti FAK (Ozyme), mouse anti-Erk1/
Erk2(SantaCruzBiotechnology), ormouse anti-paxillin(Millipore).
Statistical analysis
All experiments were performed a minimum of 3 times in
duplicate. For statistical analysis of data, Student’s t-test was used.
Values are expressed as mean 6 SD. Data were considered as
statistically significant at P values of ,.01(**) or ,.05 (*).
Results
Sb supernatant improves colonic epithelial cell restitution
To investigate any direct effect of Sb supernatant on cell
restitution, we used HCT-8/E11 cells for their wound-filling
capacity [25]. In vitro, Sb supernatant markedly enhanced wound
repair (Figure 1A) in a dose-dependent manner (not shown) with a
maximal effect obtained with a 1/8 dilution. We therefore used
this dilution in subsequent experiments. Time lapse videomicro-
scopy experiments (see supplemental video S1 and S2) revealed
that cells treated with Sb supernatant exhibited a higher rate of
migration than cells treated with a unused culture medium for Sb
(80 mm/h versus 40 mm/h). Quantification of the surface area
recovered by the cells indicated that Sb supernatant exerted its
effect as early as 1 hour after wounding and persisted for up to
5 hours (Figure 1B).
The motogenic effect of Sb supernatant was quite similar to that
observed using type I insulin-like growth factor (IGF-I), a well
known inductor of cell restitution (Figure 1C) [24]. To confirm the
Figure 1. Sb increases intestinal epithelial cell restitution. (A) Polarized HCT-8/E11 cell monolayers were wounded as described in Methods
and incubated for 5 hours with or without Sb supernatant. Phase contrast images were acquired at the indicated times (see also Supplementary data
S1 and S2). Data shown are from a representative experiment out of 5 performed. Scale bar: 300 mm. (B) HCT-8/E11 cell monolayers were wounded
and incubated with or without Sb supernatant. The percentage of wound area closed was determined at hourly intervals. Data represent the mean 6
SD of 3 separate experiments. ** P,.01. (C) HCT-8/E11 cell monolayers were wounded and incubated for 5 hours without (control) or with Sb or Sc
supernatants, or 14 nM IGF-I (IGF-I). Results are expressed as the percentage of cell migration compared to control. Data represent the mean 6 SD of
3 separate experiments. ** P,.01. (D) Polarized HT29-D4, CaCo2/TC7 and T84 cell monolayers were wounded and incubated for either 4 hours (T84)
or 20 hours (HT29-D4 and CaCO2/TC7) with or without Sb supernatant. Results are expressed as the percentage of cell migration compared to
control. Data represent the mean 6 SD of 3 separate experiments. ** P,.01.
doi:10.1371/journal.pone.0018427.g001
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supernatant on cell migration. As illustrated in Figure 1C, the
supernatant of Sc did not modulate wound repair. Furthermore,
similar results as those obtained with Sb supernatants in HCT-8/
E11 cells were observed using other polarized intestinal cell lines
including HT29-D4, T84 and CaCo2/TC7 (Figure 1D), indicat-
ing that the observed phenomenon could be common to all
intestinal cell lines. We verified by flow cytometry analysis that
T84 cells express both a2b1and av integrins indicating that the
reduced effect of Sb in this cell line was not associated with a lack
of integrin expression (not shown).
Sb-induced cell restitution is independent of cell
proliferation
To determine whether the enhanced wound repair observed in
response to Sb supernatant was caused by an increase in cell
migration and/or cell proliferation, HCT-8/E11 cells were
treated with 2.5 mg/ml mitomycin C, an inhibitor of DNA
replication, both before and during wound healing assays.
Mitomycin C did not attenuate the Sb-dependent wound repair,
indicating that Sb acts by increasing epithelial cell migration with
no effect on proliferation (Figure 2A). Furthermore, as a marker
of cell proliferation rate, the extent of BrdU incorporation into
cells was measured. As shown in Figure 2B, few nuclei of
migrating cells exhibited uptake of BrdU. Moreover, no
significant difference between untreated or Sb-treated cells was
observed. Taken together, these findings indicate that Sb
supernatant improves intestinal epithelial restitution indepen-
dently of cell proliferation.
Sb supernatant improves enterocyte crypt-villus
migration
To evaluate whether Sb supernatant regulates enterocyte
migration in vivo, C57BL6J mice were force-fed with PBS solution
with or without 1 mg/ml Sb, daily, for 1 week. This treatment did
not modify villus length (not shown). BrdU was administrated to
control and Sb force-fed mice 24 hours before death. This strategy
allowed the calculation of the rate, and extent to which BrdU-
labelled cells migrated from the crypts to the tips of the villi [26].
In control animals, BrdU-stained cells were detected mainly within
the crypts (Figure 3A). By contrast, in Sb force-fed mice, BrdU
positive cells were distributed from the crypt to the tips of the villi
(Figure 3B). Statistical analysis revealed that Sb significantly
enhanced cell migration along the crypt-villus axis (migration to
45% of villus height in Sb treated animals, compared to 20% of
villus height in controls) (Figure 3C).
To ensure that Sb did not promote the expansion of the
proliferative compartment, ki-67, a marker of proliferating cells,
was immunolocalized. As depicted in Figures 3D and 3E, ki-67
positive cells were detected only within the crypts in both control
and Sb force-fed mice. Moreover, Sb treatment did not modulate
the number of proliferating cells in the crypts (Figure 3F). These
finding indicate that Sb could modulate enterocyte migration, both
in vitro and in vivo, without affecting the proliferative compartment.
To compare the effect of the whole yeast and the yeast
supernatant, we daily administrated to the mice for one week,
either the whole yeast either the culture supernatant of S.boulardii.
A group of mice were also force-fed daily with supernatant of S.
Cerevisiae. As depicted on Figures 4A and 4C, BrdU-stained cells
Figure 2. Sb-stimulated cell restitution is independent of cell proliferation. (A) HCT-8/E11 cell monolayers were incubated for 2 hours with
(+) or without (2) 2.5 mg/mL mitomycin C, wounded and cultured for an additional 5 hours period with or without mitomycin C, in the absence or
presence of Sb supernatant. Wound closure was evaluated as described in Methods. Results are expressed as the percentage of cell migration
compared to control. Data represent the mean 6 SD of 3 separate experiments. * P,.05. (B) Confluent monolayers were wounded and incubated
with or without Sb supernatant for 4 hours. BrdU (10 mmol/L) was added and incubation continued for an additional hour. Cells that had
incorporated BrdU into their DNA were detected as described in Methods and are indicated by arrowheads. Data shown are from a representative
experiment out of 3 performed. Scale bar: 300 mm.
doi:10.1371/journal.pone.0018427.g002
S. boulardii Enhances Cell Restitution
PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e18427were detected mainly within the crypts in both control and Sc
supernatant force-fed mice. However, in Sb supernatant force-fed
mice, BrdU positive cells were distributed from the crypt to the tips
of the villi (Figures 4B and 4D). These data suggest that Sb
supernatant, but not Sc supernatant, contains molecule(s) that
induce migration of enterocytes in vivo.
a2b1 integrin collagen receptor is involved in
Sb-dependent cell restitution
Enterocyte migration requires dynamic interactions between
ECM molecules, such as laminin isoforms and collagens, and their
cell surface receptors [27]. Therefore we determined whether Sb
affected the distribution of a2 and a6 integrin subunits, receptors
of collagens and laminin, respectively. In both control and Sb
force-fed mice, a6 was detected at the basolateral surfaces of
enterocytes on the villus and in the crypt (Figure 5A and 5B). In
control mice, a2 integrin was found mainly at the lateral sites of
the enterocytes whereas it was significantly redistributed to the
basal sites in Sb force-fed mouse cells (Figure 5C and 5D). These
results suggest that a2 integrin participates in Sb-enhanced
enterocyte migration.
To confirm the role of a2b1integrin in Sb-enhanced enterocyte
migration, HCT-8/E11 cells, which express the integrins a2b1,
a3b1, a5b1, avb5, and a6b4 (unpublished data), were incubated
with function blocking anti-integrin mAbs during cell migration.
As observed in Figure 6A, in control cells only the anti-av integrin
mAb inhibited the capacity of untreated HCT-8/E11 cells to
migrate by approximately 50%. Interestingly, Sb-dependent cell
migration was also inhibited by the anti-av mAb (70%), and
additionally with the anti-a2 (40%) mAb. Altogether these data
indicate that the Sb-induced enterocyte migration depends on
a2b1 integrin. It should be noted that incubation with a mixture
containing anti-av, -a6 and -b1 integrin mAbs did not totally
abolish cell migration in either condition, suggesting the
participation of integrin-independent cell adhesion molecules in
this process.
Sb modulates a2b1 integrin-mediated adhesive
properties
As adhesion is essential for cell migration, we next examined
whether treatment with Sb supernatant could alter HCT-8/E11 cell
attachment to ECM proteins. Cells incubated with or without Sb
supernatant were allowed to attach to increasing concentrations of
purified laminin-111, or type I collagen. HCT-8/E11 cells attached
to both matrices (Figure 6B). Sb supernatant did not alter cell
adhesion to laminin-111. However, it dramatically increased the
percentage of adherent cells on the type I collagen matrix.Adhesion
assays performed in the presence of anti-integrin function blocking
mAbs revealed that a2b1 integrin is the sole receptor for type I
collagen in these cells (Figure 7). Thus, the increase in cell adhesion
to type I collagen upon Sb treatment most likely occurs through the
modulation of the a2b1 integrin functional state.
Figure 3. Sb improves mouse enterocyte migration along the crypt-villus axis without affecting crypt cell proliferation. Control and
force-fed Sb mice were injected with BrdU 24 hours before sacrifice. Small intestinal tissues were processed for immunostaining. The BrdU-labeled
enterocyte migration along the crypt-villus axis was traced on tissue sections by immunostaining with an anti-BrdU Ab (A and B) and quantitatively
assessed (C) as described in Methods. (n=5). ** P,.01. The proliferative marker ki-67 was detected in small intestine of control (D)o rSb force-fed
mice (E) and the number of ki-67 positive cells per crypt were evaluated (F) (n=5). Scale bar: 150 mm.
doi:10.1371/journal.pone.0018427.g003
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We postulated that Sb supernatant exerts its effects by
activating the a2b1 integrin. To test such a possibility, we
activated the a2b1 integrin using TS2/16, a b1i n t e g r i n
activating mAb [28]. As expected, a2b1 activation increased cell
adhesion onto type I collagen (Figure 8A). This activation also led
to an increase in cell migration such as that observed with Sb
supernatant (Figure 8B). Pretreatment of cells with integrin a2b1
activating factor improved neither Sb-stimulated cell adhesion nor
cell restitution (Figure 8A and 8B), strongly suggesting that Sb
secretes factors that activate a2b1 integrin, either directly or
indirectly.
Sb regulates the a2b1 integrin signaling pathway
After activation, integrins quickly associate within the actin
cytoskeleton and cluster together to form focal adhesions,
multimolecular complexes that contain signaling molecules
including focal adhesion kinase (FAK), paxillin and Erk1/2.
Activation of these signaling molecules leads to the modulation of
cell migration. We therefore checked the phosphorylation status of
these different key signaling molecules. As observed in Figure 9A,
cell adhesion to type I collagen promoted phosphorylation of both
FAK and paxillin on the Y397 and Y118 tyrosine residues
respectively. Interestingly, Sb supernatant increased the tyrosine
phosphorylation level of both proteins. Sb also upregulated the
tyrosine phosphorylation status of Erk1/2, another protein
associated with integrin signaling pathways (Figure 9A). We next
tested the effect on cell migration of PD 98059 and PF 573228,
inhibitors of MAPK and FAK respectively. As observed on
Figures 9B and 9C, these inhibitors fully blocked the Sb-induced
cell migration. These results confirm that Sb stimulates cell
migration through the activation of multiple signaling pathways
including activation of FAK and Erk1/2.
Figure 4. Sb supernatant but not Sc supernatant improves mouse enterocyte migration along the crypt-villus axis. Mice were daily
force-fed for one week with unused culture medium for Sb (control), Sb supernatant (Sb sn) or Sc supernatant (Sc sn) then injected with BrdU
24 hours before sacrifice. Small intestinal tissues were processed for immunostaining. The BrdU-labeled enterocyte migration along the crypt-villus
axis was traced on tissue sections by immunostaining with an anti-BrdU Ab (A, B and C) and quantitatively assessed (D) as described in Methods.
(n=5). ** P,.01. Arrow: basal site of the enterocytes. Scale bar: 150 mm.
doi:10.1371/journal.pone.0018427.g004
Figure 5. a2b1 integrin is relocalized in the intestine of Sb
force-fed mice. Intestinal tissues from control (A and C)o rSb force-
fed mice (B and D) were immunostained with Abs against a6( A and B)
or a2 integrin (C and D). Each image is a representative image taken
from tissue sections of five mice. Scale bar: 130 mm.
doi:10.1371/journal.pone.0018427.g005
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of adherence structures (Figure 10). Paxillin staining revealed that
control cells, plated on type 1 collagen, exhibited few focal
adhesion structures. However paxillin staining in Sb treated cells
displayed more focal adhesion structures that appeared to be
thicker than those observed in the control condition (Figure 10A
and 10B). Staining of focal adhesion structures on migrating cells
yielded a similar pattern (Figure 10C and 10D). This indicates
that treatment with Sb supernatant is associated with functional
and structural modifications of focal adhesion structures.
To explore whether Sb also regulates focal adhesion structures in
vivo, we analyzed the paxillin tyrosine phosphorylation status on
intestine from mice force-fed with PBS alone, or PBS containing
1 mg/ml lyophilized Sb. As depicted in Figure 10E, an anti-Y118
paxillin Ab failed to stain any structure in control C57BL6J mice.
However, in Sb force-fed mice, staining was detected, confined to
the basal surface of the enterocytes (Figure 10F). This strongly
suggests that Sb promotes the activation of adhesion structures
found in enterocytes in vivo.
Taken together these data indicate that Sb secretes factors that
strengthen a2b1/collagen interactions leading to enhanced
outside-in signaling and focal adhesion structure reorganization.
This was associated to an increase in cell migration.
Discussion
Besides a marked infiltration of inflammatory cells, epithelial
cell damage is also frequently observed in the mucosal lesions of
IBD such as ulcerative colitis, Crohn’s disease or in infectious
gastroenteritis [2]. Therefore, complete remission of such diseases
requires both the cessation of inflammation and the repair of
damaged epithelium. The development of novel therapies that
accelerate the repair of intestinal epithelium has recently begun
and various molecules are now being considered for clinical use
including epidermal growth factor in combination with mesala-
mine [29], keratinocyte growth factor [30], and hepatocyte growth
factor [31]. However, a better understanding of the biological
effects of these molecules must be ascertained, not least to identify
any undesired secondary effects, such as tumorigenesis.
In the present study, we analyzed the effect of Sb on the capacity
of intestinal epithelial cells to reseal a wound. According to our
findings, the impact of Sb on epithelial cells can be summarized as
Figure 6. Sb-stimulated cell restitution requires modulation of the interaction between a2b1 integrin and collagen. (A) HCT-8/E11 cell
monolayers were wounded and incubated with or without Sb supernatant. The monolayers were further incubated with or without (2) function-
blocking anti-integrin mAbs (10 mg/mL) 1 hour before wounding and during cell migration. Wound closure was determined as described in Methods.
Results are expressed as the percentage of cell migration compared to control. Data represent the mean 6 SD of 5 separate experiments. ** P,.01;
* P,.05. A mouse anti-DPP IV (DPPIV) mAb was used as a control for anti-integrin mAb specificity. (B) Isolated HCT-8/E11 cells were treated with or
without Sb supernatant and plated on either laminin-111 or type I collagen at the indicated concentrations. Cell-ECM adhesion was evaluated as
described in Methods. Results are expressed as the percentage of cell adhesion. Data represent the mean 6 SD of 3 separate experiments.
doi:10.1371/journal.pone.0018427.g006
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differentiated human intestinal epithelial cell lines in vitro; (2) in the
mouse intestine, Sb improves migration of enterocytes along the
crypt-villus axis; (3) Sb does not influence enterocyte proliferation
either in vitro or in vivo; (4) Sb stimulates a2b1 integrin, thus
activating molecules such as FAK, paxillin and ERK1/2, which
are associated with integrin signaling pathways and which
modulate cell-type I collagen I interaction; (5) concomitant with
this activation, Sb modulates both the structure and the activity of
focal adhesions. Taken together, these effects could contribute to
the enhancement of intestinal cell restitution.
Intestinal wound healing is initiated by the migration of
epithelial cells adjacent to the injured surface into the wound to
cover the denuded area. This process, termed epithelial restitution,
occurs within a period of minutes to hours and does not require
cell proliferation [2]. Through the use of a relevant in vitro model
[32], we have shown that Sb supernatant increased the capacity of
differentiated enterocytes to recolonize a wound. The effect of Sb
on wound healing was associated with an increase in cell motility
rather than a stimulation of cell proliferation. Indeed, wound
repair was unaffected by treatment with DNA synthesis inhibitors
such as mitomycin C and BrdU incorporation experiments
indicated that only a few proliferating cells were found in
wounded areas. Also Sb did not alter cell growth (not shown).
Furthermore, videomicroscopy experiments showed that Sb
supernatant doubled the migration rate of HCT-8/E11 cells and
Sb increased the rate of migration of enterocytes along the crypt-
villus axis in mice without affecting the proliferative compartment.
According to these data, we postulated that Sb supernatant
contains motogenic factor(s) that improve intestinal cell restitution.
Although the physiological pathways involved in intestinal
restitution remain partially unexplained, it has been proposed that
changes in cell-ECM interactions occur spatially and temporally
during this process. Studies carried out on gut tissue revealed that
ECM proteins including fibronectin, type I collagen and laminins
play a crucial role in regulating cell restitution [6,7,33]. They have
also demonstrated the requirement for the binding and interaction
of ECM-integrins such as a3b1, a6b1, a6b4 (laminins receptors),
a2b1 (collagens receptor), or avb3o ravb6 (fibronectin receptors)
for intestinal restitution [6,34]. In line with these results, we have
provided evidence for the requirement of a2b1 integrin facilitated
cell-ECM interaction for Sb-induced restitution. Sb was shown to
promote the redistribution of the collagen receptor from the lateral
to the basal membrane domain of enterocytes. Inhibition assays
using anti-integrin mAbs demonstrated that a2b1 integrins
participate in the Sb-induced cell migration, suggesting that
collagens support this process. Also, adhesion assays suggested
that Sb specifically modulates the a2b1-dependent cell interaction
with type I collagen.
The mechanisms by which Sb modulates integrin-ECM
interactions and subsequent intestinal restitution need to be
explored in more depth. However, at least two possibilities exist.
Firstly, cell restitution could be modulated through the regulation
of the integrin functional state. In accordance with this, some data
have highlighted dynamic changes in integrin affinities for ligands.
These changes are thought to occur in response to extracellular
cues, and can modify cell migration [35]. In line with these data,
we demonstrated that factors secreted by Sb can activate
a2b1integrin. Indeed, cell treatment with the b1 integrin
activating factor TS2/16 mAb [28,36] promoted the same
increase in cell adhesion as Sb. Moreover, cell pretreatment with
TS2/16 mAb did not enhance the impact of Sb on cell adhesion or
cell restitution. In addition, Sb did increase a2b1 integrin signaling
pathways.
Figure 7. a2b1 integrin is the sole receptor for type I collagen in
HCT8/E11 cells. Isolated HCT-8/E11 cells were incubated with or
without Sb supernatant in the absence (2) or presence of either anti-a2
or -a6 integrin mAbs. Cells were then seeded on type I collagen (3 mg/
ml). Cell adhesion was evaluated as described in Methods. Data
represent the mean 6 SD of 3 separate experiments. ** P,.01.
doi:10.1371/journal.pone.0018427.g007
Figure 8. Sb modulates integrin activation state. HCT-8/E11 cells
were incubated with or without Sb supernatant in the absence (2)o r
the presence of a b1 integrin-activating mAb (TS2/16) (A). Cells were
allowed to adhere to 3 mg/ml type I collagen for 30 minutes. Cell
adhesion was evaluated as described in Methods. ** P,.01. (B) Cells
were allowed to migrate as described in Methods. Results are expressed
as the percentage of cell migration compared to control. Data represent
the mean 6 SD of 3 separate experiments. ** P,.01.
doi:10.1371/journal.pone.0018427.g008
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PLoS ONE | www.plosone.org 9 March 2011 | Volume 6 | Issue 3 | e18427Sb has been shown to generate transduction pathways, including
activation of Erk1 and Erk2 in intestinal mucosal cells [11]. In the
present study, we demonstrated that Sb can modulate pathways
leading to cell migration. A large number of molecules, including
FAK, have been suggested as candidates for recruitment in
adhesion structures upon integrin activation. Furthermore these
molecules may serve as conduits for the transmission of the force
that is necessary for cell migration and for bidirectional signaling
between the cell interior and its environment [37]. FAK activation
leads to the stimulation of other signaling proteins such as paxillin,
thereby activating various signaling pathways crucial in the
regulation of cell adhesion and migration [37]. In the present
study, we demonstrated that Sb secretes factor(s) that alter the
FAK/paxillin signaling pathways. In mice, relocalization of a2b1
integrin to the basal domain of the enterocyte following Sb
treatment is associated to paxillin phosphorylation of the Y118
residue of the same domain. Also Sb increased the tyrosine
phosphorylation levels of FAK, paxillin and Erk1/2. Furthermore,
Sb-treated cells exhibited focal structures that appeared thicker
when compared to control cells. These observations clearly
indicate that cell treatment with Sb resulted in a strengthening of
a2b1/collagen interactions as shown by enhanced outside-in
signaling and focal adhesion reorganization.
Sb has been proposed to act as a shuttle able to liberate at least
1500 as yet not fully characterized molecules during intestinal
transit [38]. This large number of secreted peptidic and non-
Figure 9. Sb activates FAK, paxillin and MAPK. (A) HCT-8/E11 cells were allowed to adhere on type I collagen after Sb pretreatment. The
phosphorylation of tyrosine residues in FAK (Tyr-397 FAK), paxillin (Tyr-118 paxillin) and Thr-202/Tyr-204 in MAPK (Erk1 and Erk2) was determined
after cell lysis at the indicated times of cell adhesion. Samples were analyzed by western blot analysis. Equal amounts of protein were analyzed and
loading amounts were verified by probing the blot with anti-FAK, anti-paxillin or anti-Erk1/Erk2 Abs. The intensity of the bands was measured after
scanning of the autoradiograms. Values presented on the blots correspond to percentage of band intensity compared to control. (B and C) HCT-8/
E11 cell monolayers were wounded and incubated with or without Sb supernatant. The monolayers were further incubated with or without PD
98059, a MAPK inhibitor (B) or with or without PF 573228, a FAK inhibitor (C), 1 hour before wounding and during cell migration. Wound closure was
determined as described in Methods. Results are expressed as the percentage of wound repair. Data represent the mean+SD of 3 separate
experiments. ** P,.01.
doi:10.1371/journal.pone.0018427.g009
Figure 10. Sb modulates integrin signaling pathway both in vitro and in vivo. HCT-8/E11 cells were pretreated (B) or not (A) for 2 hours with
Sb supernatant, and then allowed to adhere to type I collagen-coated surfaces (3 mg/ml) for 30 minutes. After fixation and permeabilization, cells
were stained with an anti-paxillin Ab, the binding of which was revealed with an AlexaFluor 488-conjugated anti-mouse secondary Ab. Scale bar:
20 mm. HCT-8/E11 cell monolayers were wounded and incubated without (C) or with (D) Sb supernatant for 5 hours. Paxilin was revealed using a
specific anti-paxillin Ab. Scale bar: 20 mm. Intestinal tissues from control (E)o rSb force-fed mice (F) were immunostained with an Ab against Tyr-118
paxillin. Stainings were analyzed using a Leica confocal microscope. Scale bar: 100 mm.
doi:10.1371/journal.pone.0018427.g010
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pleiotropic effects on intestinal mucosa and therapeutic effects
on such a wide variety of gastrointestinal disorders [9,38,39].
Some of the yet unidentified molecules may interfere with host cell
signaling pathways and thereby modulate host cell behavior [38].
Indeed, Sb has been shown to secrete polyamines that are
implicated in intestinal cell maturation, enzyme expression and
membrane transport mechanisms [38]. In addition, Sb produces
other factors that reduce inflammation by blocking NF-kB
activation [21,40] and enhancing PPAR-c expression [41]. The
motogenic molecule(s) secreted by Sb remain to be elucidated.
However, our preliminary data suggest that the motogenic factor(s)
secreted by Sb is (are) an heat instable molecule(s) (result not
shown). Further studies are now needed to explore the molecular
mechanisms by which supernatant of Sb alters cell migration.
In conclusion, this report demonstrates for the first time that Sb
secretes motogenic factors that can improve intestinal restitution.
These factors exerted their effects through dynamic fine regulation
of integrin-mediated adhesion to the ECM. This could be of major
importance in the future treatment of diseases characterized by
severe mucosal injury, such as IBD or infectious diarrhea and
colitis.
Supporting Information
Video S1 HCT-8/E11 cell monolayers were wounded as
described in Methods, then placed in a temperature and CO2-
controlled chamber mounted on a Nikon TE2000 inverted
microscope. Images were captured every 5 minutes for a total
observation duration of 5 hours using a Cool SnapHQ camera
(Princeton Instrument) through a 106objective lens.
(MP4)
Video S2 HCT-8/E11 cell monolayers were wounded as
described in Methods and incubated with Sb supernatant. Plates
were placed in a temperature and CO2-controlled chamber
mounted on a Nikon TE2000 inverted microscope. Images were
captured every 5 minutes for a total observation time of 5 hours
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